BioCentury
ARTICLE | Company News

Acuity, eXegenics, Froptix Corp. deal

April 2, 2007 7:00 AM UTC

Acuity and Froptix reverse-merged with shell company EXEG to form Opko Corp., which will be located in Miami, Fla. The newco has $16 million in cash from EXEG and a $12 million line of credit from The Frost Group a private equity group led by Phillip Frost, who will become chairman and CEO of Opko. The Frost Group owned about 51% of EXEG prior to the merger. Acuity and Froptix would not disclose their ownership stakes in the newco. ...